Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

Plain-language summary

This study aims to follow the natural course of retinitis pigmentosa over time in patients whose disease is linked to changes in the PDE6A, PDE6B, and RHO genes. It enrolls patients aged 5 and older with retinitis pigmentosa associated with these genes. It is an observational study without a designated phase and is currently active but not recruiting new participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

University Hospital Tuebingen

Start date

11/17/2023

Estimated completion

3/1/2027

Countries

Germany

Related genes

Locations

• Tübingen, Germany

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Age: from 5 years of age
* Patient with PDE6A, PDE6B, and RHO-based retinitis pigmentosa
* Patient and/or legal representatives are willing and able to give written informed consent

Exclusion Criteria:

* severe general disease, that would make longer examinations not possible